Experience in diagnosis and treatment of prolactinomas in pediatric patients and young adults
Endocrinol Diabetes Nutr (Engl Ed)
.
2022 Dec;69(10):911-913.
doi: 10.1016/j.endien.2022.11.028.
Epub 2022 Nov 26.
Authors
Soraya Lanes Iglesias
1
,
Alba Megido Armada
2
,
Luis Antonio Castaño González
3
,
Edelmiro Luis Menéndez Torre
3
,
Isolina Riaño Galán
3
Affiliations
1
Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain. Electronic address: sorayalanes@gmail.com.
2
Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain.
3
Biocruces Bizkaia Health Research Institute, Barakaldo, Bizkaia, Spain.
PMID:
36446712
DOI:
10.1016/j.endien.2022.11.028
No abstract available
Publication types
Letter
MeSH terms
Child
Dopamine Agonists / therapeutic use
Humans
Pituitary Neoplasms* / diagnosis
Pituitary Neoplasms* / therapy
Prolactinoma* / diagnosis
Prolactinoma* / therapy
Young Adult
Substances
Dopamine Agonists